Clough Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30,020
| Closed | -$5.93M | – | 120 |
|
|
2024
Q3 | $5.93M | Sell |
30,020
-4,270
| -12% | -$843K | 0.61% | 51 |
|
|
2024
Q2 | $5.88M | Buy |
34,290
+31,440
| +1,103% | +$5.39M | 0.64% | 48 |
|
|
2024
Q1 | $519K | Hold |
2,850
| – | – | 0.06% | 104 |
|
|
2023
Q4 | $442K | Sell |
2,850
-650
| -19% | -$101K | 0.05% | 140 |
|
|
2023
Q3 | $522K | Hold |
3,500
| – | – | 0.06% | 129 |
|
|
2023
Q2 | $472K | Hold |
3,500
| – | – | 0.05% | 154 |
|
|
2023
Q1 | $558K | Hold |
3,500
| – | – | 0.06% | 142 |
|
|
2022
Q4 | $566K | Buy |
+3,500
| New | +$566K | 0.06% | 142 |
|
|
2021
Q2 | – | Sell |
-83,590
| Closed | -$9.05M | – | 131 |
|
|
2021
Q1 | $9.05M | Buy |
83,590
+300
| +0.4% | +$32.5K | 0.4% | 57 |
|
|
2020
Q4 | $8.93M | Sell |
83,290
-41,010
| -33% | -$4.39M | 0.63% | 63 |
|
|
2020
Q3 | $10.9M | Buy |
+124,300
| New | +$10.9M | 0.78% | 46 |
|
|
2015
Q2 | – | Sell |
-139,516
| Closed | -$8.17M | – | 192 |
|
|
2015
Q1 | $8.17M | Sell |
139,516
-174,784
| -56% | -$10.2M | 0.27% | 109 |
|
|
2014
Q4 | $20.6M | Sell |
314,300
-168,500
| -35% | -$11M | 0.74% | 47 |
|
|
2014
Q3 | $27.9M | Buy |
+482,800
| New | +$27.9M | 1.05% | 32 |
|